Relationships between biomarkers and left ventricular filling pressures at rest and during exercise in patients after

Mads J Andersen1, Mads Ersbøll2, John Bro-Jeppesen2

  • 1Department of Cardiology, Heart Center, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark; Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Insights

Biomarkers like midregional pro-A-type natriuretic peptide (MR-proANP) can help assess pulmonary capillary wedge pressure (PCWP) in patients with preserved ejection fraction after myocardial infarction. This finding aids in noninvasive monitoring of heart failure progression.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Heart Failure Management

Background:

  • Pulmonary capillary wedge pressure (PCWP) is a key prognostic indicator post-myocardial infarction (MI).
  • Noninvasive assessment of PCWP is challenging in patients with preserved ejection fraction (EF).
  • Biomarkers may offer a solution for monitoring PCWP in this population.

Purpose of the Study:

  • To investigate the association between plasma biomarkers and PCWP at rest and during exercise.
  • To determine if biomarkers can predict filling pressures in MI patients with preserved EF.

Main Methods:

  • Seventy-four patients with EF >45% post-MI underwent right heart catheterization and echocardiography.
  • Plasma levels of MR-proANP, NT-proBNP, galectin-3, copeptin, and MR-proADM were measured at rest.
  • PCWP was measured at rest and during exercise.

Main Results:

  • MR-proANP levels strongly correlated with PCWP at rest and during exercise.
  • NT-proBNP showed a weaker association with PCWP.
  • Galectin-3, copeptin, and MR-proADM were not associated with PCWP.

Conclusions:

  • Plasma MR-proANP levels are significantly associated with pulmonary capillary wedge pressure in MI patients with preserved EF.
  • MR-proANP may serve as a valuable noninvasive marker for assessing cardiac filling pressures.
  • Natriuretic peptides, especially MR-proANP, offer insights into hemodynamic status post-MI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
748
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K